€
E. Erturk et al. / Tetrahedron 68 (2012) 6463e6471
6469
tR¼33.41 min (rac-8b), m/z (%)¼322 ([Mꢁ18]þ, 14), 307 ([Mꢁ33]þ,
19), 234 (63), 219 (100), 203 (6), 177 (11), 163 (10), 105 (13); HRMS
(ESIþ): calcd for C23H32O2Na ([MþNa]þ) 363.2300, found 363.2277.
rac-9b: mp: 86e88 ꢂC; Rf¼0.09 (silica gel; hexanes/EtOAc, 9:1); FT-
IR (KBr): nmax (cmꢁ1) 3307 (s), 2961 (s), 1601 (w), 1477 (s), 1454 (s),
1427 (m), 1389 (m), 1323 (w), 1271 (m), 1231 (s), 1203 (m), 1156 (w),
1116 (s), 1077 (w), 1034 (s), 1010 (s), 950 (m), 907 (w), 878 (m), 772
(w), 754 (m), 697 (s), 652 (w), 541 (w); 1H NMR (500 MHz, CDCl3):
(ESIþ): calcd for C21H20O2Na ([MþNa]þ) 327.1361, found 327.1328.
rac-9c: Rf¼0.08 (silica gel; hexanes/EtOAc, 9:1); FT-IR (KBr): nmax
(cmꢁ1) 3434 (s), 3060 (s), 3028 (s), 2934 (s), 2835 (m), 2337 (w),
1950 (w),1883 (w), 1811 (w),1759 (w), 1672 (w),1602 (m), 1574 (w),
1547 (w), 1496 (s), 1442 (s), 1419 (s), 1329 (m), 1253 (s), 1219 (s),
1172 (s), 1093 (s), 1046 (s), 1007 (s), 914 (m), 844 (w), 794 (m), 759
(s), 700 (s), 629 (w), 598 (m); 1H NMR (500 MHz, CDCl3):
d 3.12 (s,
3H), 4.19 (m, 2H), 4.72 (t, J¼7.2 Hz, 1H), 7.17 (m, 1H), 7.21e7.25 (m,
d
1.30 (s, 9H), 1.40 (s, 9H), 3.66 (s, 3H), 4.03e4.08 (m, 1H), 4.10e4.15
(m,1H), 4.68 (t, J¼7.4 Hz,1H), 7.20e7.23 (m, 2H), 7.28e7.35 (m, 5H);
13C NMR (APT, 125 MHz, CDCl3):
31.3 (CH3), 31.5 (CH3), 34.6 (C),
2H), 7.30e7.34 (m, 5H), 7.38e7.41 (m, 3H), 7.56 (m, 2H); 13C NMR
(APT, 125 MHz, CDCl3):
d 46.8 (CH), 60.5 (CH3), 66.0 (CH2), 124.2
d
(CH), 126.6 (CH), 127.1 (CH), 127.5 (CH), 128.3 (CH), 128.4 (CH), 128.6
(CH), 128.9 (CH), 129.9 (CH), 135.0 (C), 135.1 (C), 138.7 (C), 141.7 (C),
156.0 (C); GCeMS: tR¼35.27 min (rac-9c), m/z (%)¼304 ([M]þ, 4),
286 ([Mꢁ18]þ, 4), 274 ([Mꢁ30]þ, 30), 257 (9), 239 (3), 227 (4), 207
(100), 191 (11), 177 (4), 165 (13), 133 (8), 115 (4), 103 (4), 91 (45), 73
(3); HRMS (ESIþ): calcd for C21H20O2Na ([MþNa]þ) 327.1361, found
327.1359.
35.4 (C), 46.4 (CH), 62.8 (CH3), 67.1 (CH2), 123.1 (CH), 123.7 (CH),
126.6 (CH), 128.3 (CH), 128.6 (CH), 133.2 (C), 141.6 (C), 142.3 (C),
145.7 (C), 156.4 (C); GCeMS: tR¼33.05 min (rac-9b), m/z (%)¼340
([M]þ, 37), 325 ([Mꢁ15]þ, 13), ([Mꢁ30]þ, 40), 295 (30), 281 (14),
253 (41), 207 (100), 191 (11), 178 (8), 165 (9), 147 (3), 133 (11), 119
(4), 105 (30); HRMS (ESIþ): calcd for C23H32O2Na ([MþNa]þ)
363.2300, found 363.2298.
4.6. trans-2-(2-Methoxyphenyl)-cyclohexanol (rac-11)10d
4.5. 2-(2-Methoxy-3-phenylphenyl)-1-phenylethanol (rac-8c)
and 2-(2-methoxy-3-phenylphenyl)-2-phenylethanol (rac-9c)
(Table 2, entry 9)
(Table 3, entry 1)
Cyclohexene oxide (10, 98 mg, ca. 101 mL, 1.0 mmol, 1.00 equiv)
was reacted with o-lithioanisole (6a, ca. 3.00 equiv) in the presence
of BF3$OEt2 according to the general procedure as described above.
The o-2-hydroxyalkylanisole rac-11 (204 mg, 0.99 mmol, 99%) was
first isolated by silica gel column chromatography eluting with
hexanes/EtOAc (9:1) as a colorless viscous oil, which gradually
became a colorless solid by standing. Mp: 52e54 ꢂC; Rf¼0.11 (silica
gel; hexanes/EtOAc, 9:1); FT-IR (KBr): nmax (cmꢁ1) 3372 (m), 3103
(w), 3073 (w), 3012 (w), 2919 (s), 2661 (w), 2008 (w),1911 (w),1876
(w),1756 (w) 1599 (s),1585 (s), 1492 (s), 1463 (s),1438 (s),1326 (m),
1290 (m), 1240 (s), 1191 (m), 1126 (m), 1090 (w), 1051 (s), 961 (m),
824 (w), 746 (s), 730 (s), 577 (w), 565 (w); 1H NMR (500 MHz,
An oven-dried 25 mL Schlenk tube that was capped with a glass
stopper and equipped with a magnetic stirring bar was evacuated
under heating with a blow-drier for 15 min. After the tube was
cooled down to room temperature, dry nitrogen was back-filled and
the glass stopper was replaced with a rubber septum under positive
pressure of nitrogen. 2-Phenylanisole (5b, 921 mg, ca. 985
mL,
5.0 mmol, 5.00 equiv) and TMEDA (116 mg, 150 L, 1.0 mmol,
m
1.00 equiv) were added with a syringe in the tube succeeded by the
addition of absolute Et2O (15 mL) as the solvent. After the mixture
was cooled in an ice-bath, 3.125 mL of 1.6 M solution of nBuLi in
hexanes (5.0 mmol, 5.00 equiv nBuLi) were dropwise added to the
mixture. The mixture was then stirred overnight (ca.16 h) while the
temperature was allowed to rise to room temperature. After the
reaction tube was cooled down to ꢁ78 ꢂC in a dry-ice/iso-propanol
bath, absolute THF (3 mL) was added. Styrene oxide (rac-7, 120 mg,
CDCl3):
d 1.33e1.54 (m, 4H), 1.73e1.86 (m, 4H), 2.12e2.16 (m, 1H),
2.98e3.04 (m, 1H), 3.71e3.77 (m, 1H), 3.83 (s, 3H), 6.89 (dd, J¼8.2,
1.0 Hz, 1H), 6.97 (dt, J¼7.5, 1.0 Hz,1H), 7.20 (m,1H), 7.23 (m, 1H); 13C
NMR (APT, 125 MHz, CDCl3):
d 25.1 (CH2), 26.1 (CH2), 32.3 (CH2),
35.1 (CH2), 45.0 (CH), 55.4 (CH3), 73.8 (CH), 110.7 (CH), 120.9 (CH),
127.2 (CH), 127.3 (CH), 131.5 (C), 157.6 (C); GCeMS: tR¼28.19 min
(rac-11), m/z (%)¼206 ([M]þ, 73), 188 ([Mꢁ18]þ, 7), 173 ([Mꢁ33]þ,
43), 147 (23), 134 (7), 121 (100), 107 (9), 91 (47), 77 (10); HRMS
(ESIþ): calcd for C13H18O2Na ([MþNa]þ) 229.1204, found 229.1196.
115 mL, 1.0 mmol, 1.00 equiv) and BF3$OEt2 (710 mg, 620 mL,
5.0 mmol, 5.00 equiv) were successively added to the reaction
mixture. After stirring the reaction mixture at ꢁ78 ꢂC for 1 h, re-
action was quenched by addition of saturated NaHCO3 solution
(8 mL). After the ethereal solvents were removed by rotary evap-
oration under reduced pressure, the aqueous residue was extracted
with Et2O (3ꢃ30 mL). Combined organic layers were dried over
Na2SO4. After all volatile components were removed by rotary
evaporation in vacuo, the residue was purified by silica gel column
chromatography eluting with hexanes/EtOAc (9:1). Both the o-2-
hydroxyalkylanisoles rac-8c (190 mg, 0.63 mmol, 63%) and rac-9c
(55 mg, 0.18 mmol, 18%) were isolated as colorless viscous oil by
silica gel column chromatography eluting with hexanes/EtOAc
(9:1). rac-8c: Rf¼0.15 (silica gel; hexanes/EtOAc, 9:1); FT-IR (KBr):
nmax (cmꢁ1) 3434 (s), 3060 (s), 3028 (s), 2934 (s), 2835 (m), 2337
(w), 1950 (w), 1883 (w), 1811 (w), 1759 (w), 1672 (w), 1602 (m), 1574
(w), 1547 (w), 1496 (s), 1442 (s), 1419 (s), 1329 (m), 1253 (s), 1219 (s),
1172 (s), 1093 (s), 1046 (s), 1007 (s), 914 (m), 844 (w), 794 (m), 759
4.7. trans-2-(2-Methoxyphenyl)-cyclopentanol (rac-13) (Table
3, entry 2)
Cyclopentene oxide (12, 84 mg, 87 mL, 1.0 mmol, 1.00 equiv) was
reacted with o-lithioanisole (6a, ca. 3.00 equiv) in the presence of
BF3$OEt2 according to the general procedure as described above.
The o-2-hydroxyalkylanisole rac-13 (190 mg, 0.99 mmol, 99%) was
obtained as a colorless viscous oil after silica gel column chroma-
tography eluting with hexanes/EtOAc (9:1). Rf¼0.09 (silica gel;
hexanes/EtOAc, 9:1); FT-IR (KBr): nmax (cmꢁ1) 3391 (s), 3064 (m),
3029 (m), 2955 (s), 2872 (s), 2835 (s), 2050 (w), 1893 (w), 1775 (w),
1599 (s), 1585 (s), 1492 (s), 1463 (s), 1438 (s), 1326 (m), 1290 (m),
1240 (s), 1175 (m), 1029 (s), 984 (m), 752 (s), 573 (w); 1H NMR
(s), 700 (s), 629 (w), 598 (m); 1H NMR (500 MHz, CDCl3):
d
3.0 (m,
(500 MHz, CDCl3): d 1.67e1.73 (m, 1H), 1.74e1.92 (m, 3H), 1.98e2.10
1H, OH), 3.03 (dd, J¼13.7, 8.7 Hz, 1H), 3.11 (dd, J¼13.7, 4.0 Hz, 1H),
3.33 (s, 3H), 4.99 (m, 1H), 7.06e7.11 (m, 2H), 7.18e7.26 (m, 2H), 7.33
(t, J¼7.4 Hz, 3H), 7.38e7.42 (m, 4H), 7.58 (d, J¼7.7 Hz, 2H); 13C NMR
(m, 2H), 2.44 (br s, 1H), 3.27 (dd, J¼15.5, 7.9 Hz, 1H), 3.83 (s, 3H),
4.17 (dd, J¼12.3, 6.8 Hz, 1H), 6.88 (dd, J¼8.4, 1.0 Hz, 1H), 6.93 (dt,
J¼7.5, 1.0 Hz, 1H), 7.17e7.21 (m, 2H); 13C NMR (APT, 125 MHz,
(APT, 125 MHz, CDCl3):
d
41.2 (CH2), 60.3 (CH3), 74.8 (CH), 124.2
CDCl3): d 22.8 (CH2), 30.3 (CH2), 34.3 (CH2), 48.6 (CH), 55.4 (CH3),
(CH), 125.7 (CH), 127.1 (CH), 127.3 (CH), 128.2 (CH), 128.3 (CH), 128.9
(CH), 130.0 (CH), 130.7 (CH), 131.7 (C), 134.8 (C), 138.6 (C), 144.4 (C),
155.9 (C); GCeMS: tR¼35.19 min (rac-8c), m/z (%)¼286 ([Mꢁ18]þ,
11), 270 ([Mꢁ34]þ, 1), 253 (3), 239 (3), 228 (2), 209 (40), 198 (100),
183 (20), 165 (17), 152 (16), 128 (3), 107 (21), 79 (17); HRMS
79.4 (CH), 110.4 (CH), 120.8 (CH), 126.9 (CH), 127.1 (CH), 131.5 (C),
157.5 (C); GCeMS: tR¼26.76 min (rac-13), m/z (%)¼192 ([M]þ, 68),
174 ([Mꢁ18]þ, 11), 159 ([Mꢁ33]þ, 9), 148 (14), 135 (11), 121 (100),
105 (10), 91 (50), 77 (14); HRMS (ESIþ): calcd for C12H16O2Na
([MþNa]þ) 215.1048, found 215.1042.